You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

Article info

Article menu

Download PDFPDF

XML
Clinical Trials Monitor
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

Authors

  • Jason M. Redman Genitourinary Malignancies Branch, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Dr., Room B2L312 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Seth M. Steinberg Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Dr. 20892 Bethesda MD USA Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 9609 Medical Center Drive, Room 2W334, MSC 9716 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • James L. Gulley Genitourinary Malignancies Branch, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Dr., Room B2L312 20892 Bethesda MD USA PubMed articlesGoogle scholar articles

Citation

Redman JM, Steinberg SM, Gulley JL
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
Journal for ImmunoTherapy of Cancer 2018;6:91. doi: 10.1186/s40425-018-0409-8
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.